Ordina per
Medicine and Dentistry
Patient
100%
Infection
79%
COVID-19
68%
Severe Acute Respiratory Syndrome Coronavirus 2
49%
Fecal Microbiota Transplantation
41%
Diagnosis
38%
Therapeutic Procedure
37%
Inpatient
25%
Diseases
22%
Combination Therapy
22%
Species
22%
Candidemia
19%
Assay
19%
Antifungal Agent
19%
Antifungal Therapy
17%
Clostridium Difficile Infection
17%
Mortality
17%
Bloodstream Infection
16%
Child
14%
Gut Microbiota
12%
Tuberculosis
12%
Gut
12%
Hospital
11%
Pathogen
11%
Laboratory
11%
Antifungal Susceptibility
11%
Serum
11%
Systemic Mycosis
10%
Donor
10%
Culture
9%
Development
9%
Candidiasis
9%
Analysis
9%
In Vitro
9%
Virus
9%
Ulcerative Colitis
9%
Neonatal Infant
9%
Blood Culture
8%
Matrix Assisted Laser Desorption Ionization Time of Flight Mass Spectrometry
8%
Antigen
8%
Aspergillus
8%
Invasive Aspergillosis
8%
Chemotherapeutic Agent
8%
Drug
8%
Mycosis
8%
Intensive Care Unit
8%
Evaluation Study
7%
Mycobacterium Tuberculosis
7%
Nasopharyngeal Swab
7%
Observational Study
7%
Immunology and Microbiology
Species
50%
Candida
35%
Gene
35%
Sample
33%
Biofilm
26%
COVID-19
22%
Infectious Agent
22%
Mycobacterium Tuberculosis
21%
Candida Albicans
21%
Mutant
20%
Severe Acute Respiratory Syndrome Coronavirus 2
20%
Virulence
20%
Electric Potential
15%
Time
15%
Feces microflora
13%
Minimum Inhibitory Concentration
13%
Transplantation
12%
Klebsiella pneumoniae
12%
Matrix-Assisted Laser Desorption-Ionization
12%
Polymerase Chain Reaction
12%
Cells
11%
Mortality
11%
Genotype
11%
Enterococcus faecalis
11%
Mycobacteria
11%
Wild Type
11%
Bacterium
10%
Growth
10%
Host
10%
Spectrum
10%
Mouse
10%
Surface Property
10%
Candida Glabrata
10%
Escherichia coli
10%
Intestine Flora
9%
Organisms
9%
Development
9%
Antifungal Susceptibility
9%
Macrophage
8%
Human Immunodeficiency Virus
8%
Time-of-Flight Mass Spectrometry
8%
Aspergillus
7%
Mutation
7%
Microorganism
7%
Phenotype
7%
Antimicrobial Resistance
7%
Adhesion
7%
Aptitude
6%
Monospecific Antibody
6%
Hybridization
6%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
44%
Candida
40%
Bloodstream Infection
30%
Antifungal Agent
21%
Mortality
20%
Candidemia
19%
Echinocandin
17%
Drug
16%
Fluconazole
15%
Antiinfective Agent
15%
Infectious Agent
13%
Peptide
12%
Antifungal
12%
Amphotericin B
12%
Candida Albicans
12%
Infection
11%
Systemic Mycosis
9%
Antifungal Therapy
9%
Mycosis
9%
Mycobacterium Tuberculosis
9%
Tuberculosis
8%
Antibiotics
8%
Intestine Flora
8%
Diseases
8%
Bacterium
8%
Caspofungin
8%
Invasive Candidiasis
8%
Clostridium Difficile Infection
8%
Organisms
8%
Yeast
8%
Essential Oil
8%
Hematologic Malignancy
8%
Voriconazole
8%
Pyrrole
8%
Graphene Oxide
7%
Aspergillus
7%
Incidence
7%
Anidulafungin
7%
Candida Glabrata
7%
Bloodstream Infection
7%
Protein
6%
Virulence
6%
Antifungal Activity
6%
Escherichia coli
6%
Feces microflora
6%
Vaccine Adverse Event
6%
Observational Study
6%
Candidiasis
6%
Antibiotic Agent
5%
Vaccine
5%
